These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 7589833

  • 1. Residual beta-cell function and HLA-A24 in IDDM. Markers of glycemic control and subsequent development of diabetic retinopathy.
    Nakanishi K, Kobayashi T, Inoko H, Tsuji K, Murase T, Kosaka K.
    Diabetes; 1995 Nov; 44(11):1334-9. PubMed ID: 7589833
    [Abstract] [Full Text] [Related]

  • 2. Association of HLA-A24 with complete beta-cell destruction in IDDM.
    Nakanishi K, Kobayashi T, Murase T, Nakatsuji T, Inoko H, Tsuji K, Kosaka K.
    Diabetes; 1993 Jul; 42(7):1086-93. PubMed ID: 8099884
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synchronous decline of serum-soluble HLA class I antigen and beta-cell function in insulin-dependent diabetes mellitus.
    Nakanishi K, Kobayashi T, Komatsu Y, Kogawa N, Hagihara M, Tsuji K.
    Clin Immunol Immunopathol; 1997 Dec; 85(3):246-52. PubMed ID: 9400624
    [Abstract] [Full Text] [Related]

  • 6. Relationships among islet cell antibodies, residual beta-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a sensitive C-peptide radioimmunoassay.
    Nakanishi K, Kobayashi T, Miyashita H, Ohkubo M, Sugimoto T, Murase T, Kosaka K, Inouye K, Kono M.
    Metabolism; 1990 Sep; 39(9):925-30. PubMed ID: 2202883
    [Abstract] [Full Text] [Related]

  • 7. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rate of beta-cell destruction in type 1 diabetes influences the development of diabetic retinopathy: protective effect of residual beta-cell function for more than 10 years.
    Nakanishi K, Watanabe C.
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4759-66. PubMed ID: 18826998
    [Abstract] [Full Text] [Related]

  • 10. Time course of islet cell antibodies and beta-cell function in non-insulin-dependent stage of type I diabetes.
    Kobayashi T, Itoh T, Kosaka K, Sato K, Tsuji K.
    Diabetes; 1987 Apr; 36(4):510-7. PubMed ID: 3545950
    [Abstract] [Full Text] [Related]

  • 11. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVI. The relationship of C-peptide to the incidence and progression of diabetic retinopathy.
    Klein R, Klein BE, Moss SE.
    Diabetes; 1995 Jul; 44(7):796-801. PubMed ID: 7789648
    [Abstract] [Full Text] [Related]

  • 12. Biomedical and psychiatric risk factors for retinopathy among children with IDDM.
    Kovacs M, Mukerji P, Drash A, Iyengar S.
    Diabetes Care; 1995 Dec; 18(12):1592-9. PubMed ID: 8722057
    [Abstract] [Full Text] [Related]

  • 13. High prevalence of proliferative retinopathy in diabetic patients with low pancreatic B-cell capacity.
    Suzuki K, Watanabe K, Motegi T, Kajinuma H.
    Diabetes Res Clin Pract; 1989 Jan 03; 6(1):45-52. PubMed ID: 2649341
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for progression of background retinopathy in long-standing IDDM.
    Janka HU, Warram JH, Rand LI, Krolewski AS.
    Diabetes; 1989 Apr 03; 38(4):460-4. PubMed ID: 2647552
    [Abstract] [Full Text] [Related]

  • 15. Meal-stimulated C-peptide and insulin antibodies in type I diabetic subjects and their nondiabetic siblings characterized by HLA-DR antigens.
    Hoogwerf BJ, Rich SS, Barbosa JJ.
    Diabetes; 1985 May 03; 34(5):440-5. PubMed ID: 3886461
    [Abstract] [Full Text] [Related]

  • 16. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.
    Tuomi T, Björses P, Falorni A, Partanen J, Perheentupa J, Lernmark A, Miettinen A.
    J Clin Endocrinol Metab; 1996 Apr 03; 81(4):1488-94. PubMed ID: 8636356
    [Abstract] [Full Text] [Related]

  • 17. [HLA-A24: risk factor in proliferante diabetic retinopathy].
    Asensio-Sánchez VM, Rodríguez-Delgado B, García-Herrero E, Cabo-Vaquera V, García-Loygorri C.
    Arch Soc Esp Oftalmol; 2007 Dec 03; 82(12):753-6. PubMed ID: 18040918
    [Abstract] [Full Text] [Related]

  • 18. Early risk stratification in pediatric type 1 diabetes.
    Broe R.
    Acta Ophthalmol; 2015 Mar 03; 93 Thesis 1():1-19. PubMed ID: 25703648
    [Abstract] [Full Text] [Related]

  • 19. Visual function in young IDDM patients over 8 years of age. A 4-year longitudinal study.
    North RV, Farrell U, Banford D, Jones C, Gregory JW, Butler G, Owens DR.
    Diabetes Care; 1997 Nov 03; 20(11):1724-30. PubMed ID: 9353616
    [Abstract] [Full Text] [Related]

  • 20. Microalbuminuria development in short-term IDDM.
    González-Clemente JM, Esmatjes E, Navarro P, Ercilla G, Casamitjana R, Rios M, Levy I, Gomis R, Vilardell E.
    Diabetes Res Clin Pract; 1994 May 03; 24(1):15-23. PubMed ID: 7924882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.